mRNA-4157 and Keytruda - a rainbow coming
$Moderna(MRNA.US$ Reason for long term optimism - judging by the positive tick up today for $Merck & Co(MRK.US$ following the news of a new Keytruda (pembrolizumab) combo approval today, I can only imagine that the markets will be bullish some time after June when the KEYNOTE-603 trial is published for mRNA-4157. Agreed with the sentiment that the price will go lower still, but I’ll be snapping up lots when the price seems to have bottomed
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment